Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project
Dyslipidaemia plays a major role in the pathogenesis of atherosclerosis. Every year, scientific institutions publish cardiovascular prevention guidelines with updated goals and recommendations based on new evidence. However, medical barriers exist that make achieving these goals difficult and gaps b...
Main Authors: | Ricardo Lopez Santi, Felipe Martinez, Adrian Baranchuk, Alvaro Sosa Liprandi, Daniel Piskorz, Alberto Lorenzatti, Juan Carlos Kaski |
---|---|
Format: | Article |
Language: | English |
Published: |
Radcliffe Medical Media
2021-04-01
|
Series: | European Cardiology Review |
Online Access: | https://www.ecrjournal.com/articleindex/ecr.2020.42 |
Similar Items
-
ISCP: In-depth model for selecting critical security controls
by: Al-Safwani, Nadher M. A., et al.
Published: (2018) -
New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
by: Alberto J Lorenzatti, et al.
Published: (2020-02-01) -
Neglected Tropical Diseases and Other Infectious Diseases Affecting the Heart. The NET-Heart Project: Rationale and Design
by: Lucrecia M. Burgos, et al.
Published: (2020-09-01) -
El control de la hipertensión arterial, una asignatura pendiente
by: Álvaro Sosa Liprandi, et al.
Published: (2022-09-01) -
Risk factors, comorbiditiEs and Atherogenic dysLipidaemia in Indian YOUNG patients with dyslipidaemia attending hospital/clinic: REAL YOUNG (dyslipidaemia) study
by: S S Iyengar, et al.
Published: (2020-01-01)